ACE and Alzheimer disease: We have previously shown that downstream brain RAS pathways in the FCx are disturbed in AD—ACE-1 activity and Ang-II levels are elevated in AD, as are Ang-III levels (12), whereas ACE-2 activity is significantly reduced in AD (11).